Skip to Content

125/DPI (Estropipate 1.5 mg)

Pill with imprint 125/DPI is , and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 125/DPI

Estropipate

Imprint
125/DPI
Strength
1.5 mg
Availability
Prescription only
Drug Class
Estrogens
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00364-2601

Get help with Imprint Code FAQs.

Related Images for "125/DPI"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.